Semaglutide, Tirzepatide, Retatrutide and Cagrilintide are often lumped together, but they are not doing the same thing. : r Wegovy Tirzepatide Injectable Peptide EASD 2023: meta analysis shows tirzepatide superiority to semaglutide Clinical Trials Arena Lab Grade Tirzepatide for Canadian Researchers Ambros Labs Tirzepatide Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit